CRTAM receptor engagement by Necl-2 on tumor cells triggers cell death of activated Vγ9Vδ2 T cells

Journal of Immunology

Volumn 190, Issue 9, 2013, Pages 4868-4876

  Dessarthe, Benoît ^a   Thedrez, Aurélie ^a   Latouche, Jean Baptiste ^b   Cabillic, Florian ^a,d   Drouet, Aurélie ^b   Daniel, Pascale ^c   Thomas De La Pintière, Cécile ^c   Catros, Véronique ^a,c   Toutiraisx, Olivier ^e  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^b ROUEN UNIVERSITY HOSPITAL   (France)

^c RENNES UNIVERSITY HOSPITAL   (France)

^d UNIVERSITÉ DE CAEN   (France)

^e CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CLASS I RESTRICTED T CELL ASSOCIATED MOLECULE RECEPTOR; GAMMA INTERFERON; NECL 2 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; AUTOPHAGY; CELL DEATH; CELL EXPANSION; CELL MEDIATED CYTOTOXICITY; CELL SURFACE; CELL SURVIVAL; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; EFFECTOR CELL; HUMAN; HUMAN CELL; MOUSE; NECROPTOSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RECEPTOR DOWN REGULATION; T LYMPHOCYTE ACTIVATION; TUMOR IMMUNOLOGY;

ANTIGENS; AUTOPHAGY; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CELL MEMBRANE; CYTOTOXICITY, IMMUNOLOGIC; DOWN-REGULATION; HEP G2 CELLS; HT29 CELLS; HUMANS; IMMUNOGLOBULINS; IMMUNOTHERAPY; INTERFERON-GAMMA; K562 CELLS; NEOPLASMS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; RECEPTORS, NATURAL KILLER CELL; T-LYMPHOCYTES;

EID: 84876793915     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202596     Document Type: Article

References (44)

1. Morita, C. T., C. Jin, G. Sarikonda, and H. Wang. 2007. Nonpeptide antigens, presentation mechanisms, and immunological memory of human Vgamma2V-delta2 T cells: discriminating friend from foe through the recognition of prenyl pyrophosphate antigens. Immunol. Rev. 215: 59-76. (Pubitemid 46212230)
2. Corvaisier, M., A. Moreau-Aubry, E. Diez, J. Bennouna, J.-F. Mosnier, E. Scotet, M. Bonneville, and F. Jotereau. 2005. V gamma 9V delta 2 T cell response to colon carcinoma cells. J. Immunol. 175: 5481-5488. (Pubitemid 41456435)
3. Viey, E., G. Fromont, B. Escudier, Y. Morel, S. Da Rocha, S. Chouaib, and A. Caignard. 2005. Phosphostim-activated gamma delta T cells kill autologous metastatic renal cell carcinoma. J. Immunol. 174: 1338-1347.
4. Bouet-Toussaint, F., F. Cabillic, O. Toutirais, M. Le Gallo, C. Thomas de la Pintière, P. Daniel, N. Genetet, B. Meunier, E. Dupont-Bierre, K. Boudjema, and V. Catros. 2008. Vgamma9Vdelta2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas. Cancer Immunol. Immunother. 57: 531-539. (Pubitemid 351170536)
5. Toutirais, O., F. Cabillic, G. Le Friec, S. Salot, P. Loyer, M. Le Gallo, M. Desille, C. T. de La Pintière, P. Daniel, F. Bouet, and V. Catros. 2009. DNAX accessory molecule-1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vgamma9Vdelta2 T cells. Eur. J. Immunol. 39: 1361-1368.
6. Gomes, A. Q., D. S. Martins, and B. Silva-Santos. 2010. Targeting gd T lymphocytes for cancer immunotherapy: from novel mechanistic insight to clinical application. Cancer Res. 70: 10024-10027.
7. Hannani, D., Y. Ma, T. Yamazaki, J. Déchanet-Merville, G. Kroemer, and L. Zitvogel. 2012. Harnessing gd T cells in anticancer immunotherapy. Trends Immunol. 33: 199-206.
8. Gober, H.-J., M. Kistowska, L. Angman, P. Jenö, L. Mori, and G. De Libero. 2003. Human T cell receptor gammadelta cells recognize endogenous mevalo-nate metabolites in tumor cells. J. Exp. Med. 197: 163-168. (Pubitemid 36152311)
9. Gertner-Dardenne, J., C. Bonnafous, C. Bezombes, A.-H. Capietto, V. Scaglione, S. Ingoure, D. Cendron, E. Gross, J.-F. Lepage, A. Quillet-Mary, et al. 2009. Bromohydrin pyrophosphate enhances antibody-dependent cell-mediated cyto-toxicity induced by therapeutic antibodies. Blood 113: 4875-4884.
10. Bukowski, J. F., C. T. Morita, Y. Tanaka, B. R. Bloom, M. B. Brenner, and H. Band. 1995. V gamma 2V delta 2 TCR-dependent recognition of non-peptide antigens and Daudi cells analyzed by TCR gene transfer. J. Immunol. 154: 998-1006.
11. Bonneville, M., R. L. O'Brien, and W. K. Born. 2010. Gammadelta T cell effector functions: a blend of innate programming and acquired plasticity. Nat. Rev. Immunol. 10: 467-478.
12. Groh, V., R. Rhinehart, H. Secrist, S. Bauer, K. H. Grabstein, and T. Spies. 1999. Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc. Natl. Acad. Sci. USA 96: 6879-6884. (Pubitemid 29274978)
13. Fuchs, A., and M. Colonna. 2006. The role of NK cell recognition of nectin and nectin-like proteins in tumor immunosurveillance. Semin. Cancer Biol. 16: 359-366. (Pubitemid 44311500)
14. Chan, C. J., D. M. Andrews, and M. J. Smyth. 2012. Receptors that interact with nectin and nectin-like proteins in the immunosurveillance and immunotherapy of cancer. Curr. Opin. Immunol. 24: 246-251.
15. Takai, Y., J. Miyoshi, W. Ikeda, and H. Ogita. 2008. Nectins and nectin-like molecules: roles in contact inhibition of cell movement and proliferation. Nat. Rev. Mol. Cell Biol. 9: 603-615. (Pubitemid 352032927)
16. Kennedy, J., A. P. Vicari, V. Saylor, S. M. Zurawski, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, and A. Zlotnik. 2000. A molecular analysis of NKT cells: identification of a class-I restricted T cell-associated molecule (CRTAM). J. Leukoc. Biol. 67: 725-734.
17. Boles, K. S., W. Barchet, T. Diacovo, M. Cella, and M. Colonna. 2005. The tumor suppressor TSLC1/NECL-2 triggers NK-cell and CD8+ T-cell responses through the cell-surface receptor CRTAM. Blood 106: 779-786. (Pubitemid 41076415)
18. Arase, N., A. Takeuchi, M. Unno, S. Hirano, T. Yokosuka, H. Arase, and T. Saito. 2005. Heterotypic interaction of CRTAM with Necl2 induces cell adhesion on activated NK cells and CD8+ T cells. Int. Immunol. 17: 1227-1237. (Pubitemid 41244520)
19. Kuramochi, M., H. Fukuhara, T. Nobukuni, T. Kanbe, T. Maruyama, H. P. Ghosh, M. Pletcher, M. Isomura, M. Onizuka, T. Kitamura, et al. 2001. TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer. Nat. Genet. 27: 427-430. (Pubitemid 32268425)
20. Yeh, J.-H., S. S. Sidhu, and A. C. Chan. 2008. Regulation of a late phase of T cell polarity and effector functions by Crtam. Cell 132: 846-859. (Pubitemid 351312800)
21. Takeuchi, A., Y. Itoh, A. Takumi, C. Ishihara, N. Arase, T. Yokosuka, H. Koseki, S. Yamasaki, Y. Takai, J. Miyoshi, et al. 2009. CRTAM confers late-stage activation of CD8+ T cells to regulate retention within lymph node. J. Immunol. 183: 4220-4228.
22. Pellissier, F., A. Gerber, C. Bauer, M. Ballivet, and V. Ossipow. 2007. The adhesion molecule Necl-3/SynCAM-2 localizes to myelinated axons, binds to oligodendrocytes and promotes cell adhesion. BMC Neurosci. 8: 90.
23. Fauquembergue, E., O. Toutirais, D. Tougeron, A. Drouet, M. Le Gallo, M. Desille, F. Cabillic, C. T. de La Pintière, M. Iero, L. Rivoltini, et al. 2010. HLA-A*0201-restricted CEA-derived peptide CAP1 is not a suitable target for T-cell-based immunotherapy. J. Immunother. 33: 402-413.
24. Visagie, M. H., and A. M. Joubert. 2012. 2-Methoxyestradiol-bis- sulphamate refrains from inducing apoptosis and autophagy in a non-tumorigenic breast cell line. Cancer Cell Int. 12: 37.
25. Goussetis, D. J., J. K. Altman, H. Glaser, J. L. McNeer, M. S. Tallman, and L. C. Platanias. 2010. Autophagy is a critical mechanism for the induction of the antileukemic effects of arsenic trioxide. J. Biol. Chem. 285: 29989-29997.
26. Galibert, L., G. S. Diemer, Z. Liu, R. S. Johnson, J. L. Smith, T. Walzer, M. R. Comeau, C. T. Rauch, M. F. Wolfson, R. A. Sorensen, et al. 2005. Nectin-like protein 2 defines a subset of T-cell zone dendritic cells and is a ligand for class-I-restricted T-cell-associated molecule. J. Biol. Chem. 280: 21955-21964. (Pubitemid 40827848)
27. Davis, D. M. 2007. Intercellular transfer of cell-surface proteins is common and can affect many stages of an immune response. Nat. Rev. Immunol. 7: 238-243.
28. Espinosa, E., J. Tabiasco, D. Hudrisier, and J.-J. Fournié. 2002. Synaptic transfer by human gamma delta T cells stimulated with soluble or cellular antigens. J. Immunol. 168: 6336-6343. (Pubitemid 34620056)
29. Vanherberghen, B., K. Andersson, L. M. Carlin, E. N. M. Nolte-'t Hoen, G. S. Williams, P. Höglund, and D. M. Davis. 2004. Human and murine inhibitory natural killer cell receptors transfer from natural killer cells to target cells. Proc. Natl. Acad. Sci. USA 101: 16873-16878. (Pubitemid 39601331)
30. Roda-Navarro, P., M. Vales-Gomez, S. E. Chisholm, and H. T. Reyburn. 2006. Transfer of NKG2D and MICB at the cytotoxic NK cell immune synapse correlates with a reduction in NK cell cytotoxic function. Proc. Natl. Acad. Sci. USA 103: 11258-11263. (Pubitemid 44156506)
31. Onfelt, B., S. Nedvetzki, K. Yanagi, and D. M. Davis. 2004. Cutting edge: Membrane nanotubes connect immune cells. J. Immunol. 173: 1511-1513. (Pubitemid 38971579)
32. Galluzzi, L., I. Vitale, J. M. Abrams, E. S. Alnemri, E. H. Baehrecke, M. V. Blagosklonny, T. M. Dawson, V. L. Dawson, W. S. El-Deiry, S. Fulda, et al. 2012. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ. 19: 107-120.
33. He, M.-X., I. X. McLeod, W. Jia, and Y.-W. He. 2012. Macroautophagy in T lymphocyte development and function. Front Immunol 3: 22.
34. Li, C., E. Capan, Y. Zhao, J. Zhao, D. Stolz, S. C. Watkins, S. Jin, and B. Lu. 2006. Autophagy is induced in CD4+ T cells and important for the growth factor-withdrawal cell death. J. Immunol. 177: 5163-5168. (Pubitemid 44527588)
35. Sun, T., Y. Yan, Y. Zhao, F. Guo, and C. Jiang. 2012. Copper oxide nanoparticles induce autophagic cell death in A549 cells. PLoS ONE 7: e43442.
36. Valle-Rios, R., G. Patiño-Lopez, O. Medina-Contreras, E. Canche-Pool, F. Recillas-Targa, E. Lopez-Bayghen, A. Zlotnik, and V. Ortiz-Navarrete. 2009. Characterization of CRTAM gene promoter: AP-1 transcription factor control its expression in human T CD8 lymphocytes. Mol. Immunol. 46: 3379-3387.
37. Takai, Y., K. Irie, K. Shimizu, T. Sakisaka, and W. Ikeda. 2003. Nectins and nectin-like molecules: roles in cell adhesion, migration, and polarization. Cancer Sci. 94: 655-667. (Pubitemid 37160921)
38. Murakami, Y. 2005. Involvement of a cell adhesion molecule, TSLC1/IGSF4, in human oncogenesis. Cancer Sci. 96: 543-552. (Pubitemid 41488417)
39. Sasaki, H., I. Nishikata, T. Shiraga, E. Akamatsu, T. Fukami, T. Hidaka, Y. Kubuki, A. Okayama, K. Hamada, H. Okabe, et al. 2005. Overexpression of a cell adhesion molecule, TSLC1, as a possible molecular marker for acute-type adult T-cell leukemia. Blood 105: 1204-1213. (Pubitemid 40170895)
40. Ito, A., M. Hagiyama, T. Mimura, M. Matsumoto, T. Wakayama, S. Iseki, H. Yokozaki, and M. Okada. 2008. Expression of cell adhesion molecule 1 in malignant pleural mesothelioma as a cause of efficient adhesion and growth on mesothelium. Lab. Invest. 88: 504-514. (Pubitemid 351581450)
41. Kitamura, Y., G. Kurosawa, M. Tanaka, M. Sumitomo, C. Muramatsu, K. Eguchi, Y. Akahori, Y. Iba, H. Tsuda, M. Sugiura, et al. 2009. Frequent overexpression of CADM1/IGSF4 in lung adenocarcinoma. Biochem. Biophys. Res. Commun. 383: 480-484.
42. Kuipers, J. E., E. A. Coenen, B. V. Balgobind, J. Stary, A. Baruchel, V. de Haas, E. S. J. M. de Bont, D. Reinhardt, G. J. L. Kaspers, J. Cloos, et al. 2011. High IGSF4 expression in pediatric M5 acute myeloid leukemia with t(9;11)(p22; q23). Blood 117: 928-935.
43. Kikuchi, S., M. Iwai, M. Sakurai-Yageta, Y. Tsuboi, T. Ito, T. Maruyama, H. Tsuda, Y. Kanai, M. Onizuka, Y. Sato, and Y. Murakami. 2012. Expression of a splicing variant of the CADM1 specific to small cell lung cancer. Cancer Sci. 103: 1051-1057.
44. Lu, B., and O. J. Finn. 2008. T-cell death and cancer immune tolerance. Cell Death Differ. 15: 70-79. (Pubitemid 350286174)